OptimumBank Holdings, Inc. (OPHC) is a Florida-based bank holding company for OptimumBank, a community bank headquartered in Fort Lauderdale. Coverage is thin but constructive: three analysts tracked by S&P Global carry a Strong Buy consensus, with individual targets of $10.50, $11.00 and $11.25. The average analyst price target of $10.92 rounds to the $11 central target used here.
The targets were raised sharply in 2026 as results improved. Alliance Global Partners raised its target to $11 from $7 in August 2026 while keeping a Buy rating. Brean Capital's Christopher Marinac initiated coverage earlier with a Buy and an $8 target, and Compass Point upgraded the shares to Buy from Neutral in May 2026. Because the two older, lower targets predate the re-rating, the current $10.50–$11.25 band better reflects today's expectations. Consensus EPS estimates are roughly $1.16 for fiscal 2026 and $1.31 for 2027, implying a forward P/E below roughly 10x on the near-term figure. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
With shares recently quoted around $9.12, the move to $11 represents about 21% upside — a substantial gain for a single year. The stock trades well off its 52-week low of $3.97 but below its 52-week high of $10.68, meaning the central target sits modestly above the prior peak. The company generated roughly $56.9 million in revenue and $20.5 million in net income over the trailing twelve months, with a trailing P/E near 10x and return on equity of about 16.7%. Reaching the target would likely require continued earnings expansion, sustained loan growth and confirmation that the stock's recent re-rating can be supported by fundamentals rather than momentum.
The $10.68 level — the stock's 52-week high — is the most relevant resistance level, sitting just below the $11 central target. A decisive break above it would place the target within reach, while failure there could mark a near-term ceiling. On the downside, the 50-day moving average near $8.95 and the 200-day moving average near $6.75 frame key support levels. With a beta of roughly 0.28, the shares have historically been less volatile than the broader market, though the extended run-up suggests sentiment, not just fundamentals, is now a factor.
Analyst price targets typically reflect a roughly 12-month horizon, and these targets were last updated in August 2026. The most important near-term event is the next earnings report, scheduled around November 13, 2026, which should clarify revenue growth, net interest margin and credit provisioning. Investors should also watch for analyst target revisions, updates on the OptimumFunding rollout, deposit-cost trends, and any shift in the Federal Reserve's interest-rate path, which directly affects regional-bank profitability.
In my research process I turned to Tickeron’s AI Daily Buy/Sell Signals to monitor OPHC alongside other names. The tool uses artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell or Hold signals based on changing market conditions, technical behavior and AI-driven analysis. It helps me discover new opportunities, monitor existing positions and spot shifting trends more efficiently than manual screening.
The $11 central target is a modest, analyst-derived average — the mean of three verified targets spanning $10.50 to $11.25 — and implies about 21% upside from the recent price near $9.12. The case rests on accelerating earnings, clean credit and new lending initiatives, while the principal obstacles are an already-extended stock, Florida commercial-real-estate concentration and a thin analyst base. With all three covering analysts positive but targets closely clustered, the key question is execution: whether loan growth and profitability can keep validating the re-rating. No outcome is guaranteed, and the target should be read as a research benchmark rather than a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for OPHC crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on OPHC as a result. In 69 of 115 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
Following a +1.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPHC advanced for three days, in 138 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 170 of 260 cases where OPHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 32 of 61 cases where OPHC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 52%.
The Moving Average Convergence Divergence Histogram (MACD) for OPHC turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 30 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 59%.
OPHC moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
OPHC broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.830) is normal, around the industry mean (1.262). P/E Ratio (5.624) is within average values for comparable stocks, (13.479). Projected Growth (PEG Ratio) (0.180) is also within normal values, averaging (1.190). Dividend Yield (0.000) settles around the average of (0.035) among similar stocks. P/S Ratio (3.643) is also within normal values, averaging (3.738).
The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. OPHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks